News

SynDaver™ Labs has developed ultra-realistic vas deferens, ureter, and prostate organs for robotic micro-anastomosis training on the DaVinci® robotic surgery system. These organs will premiere at the upcoming first annual RAMSES course in Orlando, Florida.

Imagine practicing IV starts, chest decompressions and intubations on synthetic human tissue and body systems that are identical to real tissue. Through the work of SynDaver™ Labs, that day has arrived. Read more in the latest issue of EMS World Magazine »

SynDaver™ Labs has developed new transparent and translucent vascular constructions based on synthetic human cornea and arterial intima. Transparent and opaque silicone-hydrogel composite vessels are now available as well, to be launched first as straight sections followed by branches and other complex shapes.

After nearly twenty years of basic materials research, more than ten years of live tissue testing, and two years of alpha and beta testing, the SynDaver™ Synthetic Human officially launched today. This technology features removable and replaceable bones, muscles, tendons, veins, arteries, nerves, organs, and skin – all made from our experimentally validated library of SynTissue™ synthetic human tissues. The first product in this line is the female torso, to be followed in Q4 2011 by the full female body, and the full male body in Q2 2012.

Customers purchasing the SynDaver™ Synthetic Human will receive no-cost upgrades to tissues, organs, and anatomical systems as they become available for a period of two years after purchase. Comprehensive extended service contracts are also available.

Pre-release testing on our SynDaver™ Synthetic Human Torso has begun! Site selection is complete and product is now being built for delivery to the 10 U.S. beta testers. These institutions include a cross-section of the finest military, medical device, and educational institutions in the country.

The beta model includes every muscle and bone in the human torso, a simplified heart with primary venous and arterial systems, trachea, lungs, and diaphragm, esophagus, stomach, large intestine, and small intestine, liver, pancreas, spleen, and gall bladder, as well as both kidneys and urinary bladder. The model supplied to beta testers is unisex.

In-depth testing will focus on compatability with a wide range of surgical devices such as laser scalpels, cryoablation catheters, radio-frequency ablation devices, harmonic blades, bovies, staple guns, puncture closure device, ventilators, airway devices, chest tubes and drains, coronary stent delivery systems, embolectomy catheters, and many other devices.

SynDaver™ Labs recently launched a new line of synthetic heart valves. Our new heart valve designer will allow clients to build aortic and mitral valves in a large variety of sizes (12mm – 42mm OD) in either healthy or diseased tissue format. These valves are typically combined with our aorta, vena cava, and heart models, and are currently being used by major medical device manufacturers in design verification and validation tests as well as clinical training applications. Pathologies include calcification, stenosis, and bacterial colonization.

A synthetic human arm designed and manufactured by SynDaver™ Labs was used by IVIR Inc (Sarasota, FL) in a Phase 2 award from U.S. Army Research, Development and Engineering Command Simulation and Training Technology Center (RDECOM STTC). The overall effort is intended to field more realistic upper extremity partial task trainers.

SynDaver™ Labs is developing platforms to enable world-class surgical training on the cheap. Read about our efforts to improve surgical simulation in the latest issue of Surgical Products magazine »

SynDaver™ Labs has developed new vein and artery constructions in millimeter and submillimeter (0.1mm, 0.2mm, 0.3mm, 0.4mm, 0.5mm, 0.6mm, 0.7mm, 0.8mm, and 0.9mm) sizes. The new vessel types are now sold as straight sections with branches and other complex structures available on a special-order basis. These vessels are ideal for microvascular anastomosis training.